|
WEDNESDAY, July 5 (HealthDay News) -- The first generic versions of the popular antidepressant Zoloft (sertraline) have been approved by the U.S. Food and Drug Administration. Last year, Pfizer''s Zoloft was the sixth-best selling drug in the United States with retail sales of more than $2.5 billion, the agency said in a statement. The company''s patent expired last week. Israeli generic drugmaker Teva Pharmaceuticals plans to launch its version of Zoloft later this month, the Associated Press reported. Generics, less expensive than brand-name equivalents, accounted for about two-thirds of U.S. prescription drug sales in 2004, the FDA said. More information For more information about Zoloft, visit the National Library of Medicine.
Last Updated: July 5, 2006 |